weight-loss drug

    Arena to License Weight-Loss Drug to Eisai in U.S.; Shares Spike

    By Melly Alazraki

    | 7:50AM 7/01/2010
    Arena Pharmaceuticals (ARNA) said Thursday it has agreed with Japan's Eisai to a licensing deal for its weight-loss drug that's worth potentially more than $1.3 billion. ARNA shares spiked over 20% in earlier premarket trading, but have cooled off somewhat and are 15% higher in recent...
    Continue reading »